Achieving high HPV vaccine completion rates in a pediatric clinic population

被引:18
作者
Berenson, Abbey B. [1 ]
Rupp, Richard [1 ]
Dinehart, Erin E. [1 ,2 ]
Cofie, Leslie E. [1 ,3 ]
Kuo, Yong-Fang
Hirth, Jacqueline M. [1 ]
机构
[1] Univ Texas Med Branch, Obstet & Gynecol, Galveston, TX 77555 USA
[2] George Washington Univ, Obstet & Gynecol, Washington, DC USA
[3] East Carolina Univ, Dept Hlth Educ & Promot, Geenville, NC USA
基金
美国国家卫生研究院;
关键词
Cancer prevention; HPV vaccine; Human papillomavirus (HPV); intervention; patient navigation; HUMAN-PAPILLOMAVIRUS VACCINES; PHYSICIAN COMMUNICATION; ADOLESCENTS; SAFETY; IMMUNOGENICITY; INTERVENTIONS; COVERAGE; CANCER;
D O I
10.1080/21645515.2018.1533778
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: To evaluate the efficacy of an intervention utilizing patient navigators (PNs) to 1) educate families on human papillomavirus (HPV) vaccination in a clinic setting and 2) provide personalized reminders for follow-up.Method: Families with 9-17year-old children who had no record of completing the HPV vaccination series receiving primary or specialty care in 3 pediatric clinics were approached by PNs between February 1, 2015 and August 31, 2016. Demographic characteristics, visit type, preferred contact method, rates and correlates of completion, and appointments missed were analyzed. In addition, qualitative interviews of 21 providers and PNs assessed their perceptions of the program.Results: 1,391 adolescents were identified out of 2,162 patients approached as unvaccinated or partially vaccinated prior starters; among the unvaccinated, 930 received the 1st dose after being counseled by the PN (66.9%), either immediately or at a follow-up visit soon thereafter. This included 118 siblings of patients who did not have an appointment that day. Of initiators approached between 2/1/2015 and 8/31/2016, 93% (864/930) completed the series by 8/31/2017. No differences in series completion among initiators were observed by gender or race/ethnicity, but older patients (15-17years old) were less likely to complete than 11-12year olds. Of the 688 patients identified as prior starters, 85% completed the series through the program. Qualitative interviews demonstrated that providers felt the program addressed major barriers to HPV vaccination.Conclusion: Employing PNs dramatically increased HPV vaccine series completion among boys and girls with historically low HPV vaccination rates at pediatric clinics in Texas. Clinic providers felt this program addressed many barriers they observed prior to program implementation. This approach could markedly improve HPV vaccine series completion rates in the US.
引用
收藏
页码:1562 / 1569
页数:8
相关论文
共 36 条
[1]   Sexuality Talk During Adolescent Health Maintenance Visits [J].
Alexander, Stewart C. ;
Fortenberry, J. Dennis ;
Pollak, Kathryn I. ;
Bravender, Terrill ;
Davis, J. Kelly ;
Ostbye, Truls ;
Tulsky, James A. ;
Dolor, Rowena J. ;
Shields, Cleveland G. .
JAMA PEDIATRICS, 2014, 168 (02) :163-169
[2]   The effectiveness of patient navigation to improve healthcare utilization outcomes: A meta-analysis of randomized controlled trials [J].
Ali-Faisal, Sobia F. ;
Colella, Tracey J. F. ;
Medina-Jaudesa, Naomi ;
Scott, Lisa Benz .
PATIENT EDUCATION AND COUNSELING, 2017, 100 (03) :436-448
[3]  
American Academy of Pediatrics, 2006, PER SURV 66 PED ATT
[4]  
[Anonymous], 2018, KEY STAT CERV CANC
[5]   Relationship between maternal experiences and adolescent HPV vaccination [J].
Berenson, Abbey B. ;
Brown, V. Gnaukita ;
Fuchs, Erika L. ;
Hirth, Jacqueline M. ;
Chang, Mihyun .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (09) :2150-2154
[6]   A brief educational intervention increases providers' human papillomavirus vaccine knowledge [J].
Berenson, Abbey B. ;
Rahman, Mahbubur ;
Hirth, Jacqueline M. ;
Rupp, Richard E. ;
Sarpong, Kwabena O. .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) :1331-1336
[7]   Immunogenicity and safety of the 9-valent HPV vaccine in men [J].
Castellsague, X. ;
Giuliano, A. R. ;
Goldstone, S. ;
Guevara, A. ;
Mogensen, O. ;
Palefsky, J. M. ;
Group, T. ;
Shields, C. ;
Liu, K. ;
Maansson, R. ;
Luxembourg, A. ;
Kaplan, S. S. .
VACCINE, 2015, 33 (48) :6892-6901
[8]  
Center for Disease Control and Prevention, HPV HUM PAP VACC WHA
[9]  
Centers for Disease Control and Prevention (CDC), 2018, DIS VACC PREV THEM H
[10]  
Centers for Disease Control and Prevention (CDC), WHAT PAR SHOULD KNOW